Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis
暂无分享,去创建一个
[1] P. Reynier,et al. Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis , 2022, Biomedicines.
[2] Peng Wu,et al. Comparative Assessment of Blood Metal/metalloid levels, Clinical Heterogeneity, and Disease Severity in Amyotrophic Lateral Sclerosis Patients. , 2022, Neurotoxicology.
[3] Y. Aksoy,et al. Protective Effects of Antioxidant Chlorophyllin in Chemically Induced Breast Cancer Model In vivo , 2021, Biological Trace Element Research.
[4] E. Scilingo,et al. Using blood data for the differential diagnosis and prognosis of motor neuron diseases: a new dataset for machine learning applications , 2021, Scientific Reports.
[5] M. Karajibani,et al. The Relationship Between Malnutrition and Liver Enzymes in Hospitalized Children in Zahedan: A Case-control Study , 2021, Zahedan Journal of Research in Medical Sciences.
[6] Qi-Jie Zhang,et al. Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis , 2021, Annals of clinical and translational neurology.
[7] S. Sardi,et al. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis , 2021, Scientific reports.
[8] K. Borges,et al. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target? , 2021, Cell & Bioscience.
[9] L. H. van den Berg,et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[10] Y. Pawitan,et al. Blood biomarkers and prognosis of amyotrophic lateral sclerosis , 2020, European journal of neurology.
[11] N. N. Ulusu,et al. Evaluation of the biocompatibility of the GSH-coated Ag2S quantum dots in vitro: a perfect example for the non-toxic optical probes , 2020, Molecular Biology Reports.
[12] C. Tiribelli,et al. Bilirubin and inflammation in neurodegenerative and other neurological diseases , 2020 .
[13] T. Woodruff,et al. The Peripheral Immune System and Amyotrophic Lateral Sclerosis , 2020, Frontiers in Neurology.
[14] N. N. Ulusu,et al. Importance of the serum biochemical parameters as potential biomarkers for rapid diagnosis and evaluating preclinical stage of ALS. , 2020, Medical hypotheses.
[15] N. N. Ulusu,et al. Dataset of the analyzing trace elements and minerals via ICP-MS: Method validation for the mammalian tissue and serum samples , 2020, Data in Brief.
[16] N. N. Ulusu,et al. Comment on the: Molecular mechanism of CAT and SOD activity change under MPA-CdTe quantum dots induced oxidative stress in the mouse primary hepatocytes (Spectrochim Acta A Mol Biomol Spectrosc. 2019 Sep 5; 220:117104). , 2019, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[17] N. N. Ulusu,et al. Effects of butylparaben on antioxidant enzyme activities and histopathological changes in rat tissues , 2019, Arhiv za higijenu rada i toksikologiju.
[18] Ehsan Sarayloo,et al. Rosiglitazone-induced changes in the oxidative stress metabolism and fatty acid composition in relation with trace element status in the primary adipocytes , 2019, Journal of medical biochemistry.
[19] Stanley E. Lazic,et al. Determining organ weight toxicity with Bayesian causal models: Improving on the analysis of relative organ weights , 2019, bioRxiv.
[20] F. Fang,et al. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature , 2019, Current opinion in neurology.
[21] J. González de Aguilar. Lipid Biomarkers for Amyotrophic Lateral Sclerosis , 2019, Front. Neurol..
[22] A. Musarò,et al. Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options , 2019, Scientific Reports.
[23] A. Chiò,et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort , 2019, Journal of Neurology Neurosurgery & Psychiatry.
[24] N. N. Ulusu,et al. Impact of the Di(2-Ethylhexyl) Phthalate Administration on Trace Element and Mineral Levels in Relation of Kidney and Liver Damage in Rats , 2018, Biological Trace Element Research.
[25] K. Torén,et al. Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood , 2017, Journal of Neurology.
[26] H. Shang,et al. Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival , 2017, Molecular Neurodegeneration.
[27] P. Shaw,et al. The role of mitochondria in amyotrophic lateral sclerosis , 2017, Neuroscience Letters.
[28] R. Mariotti,et al. ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles , 2017, Front. Cell. Neurosci..
[29] Margaret Warner,et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis[S] , 2016, Journal of Lipid Research.
[30] Shishira S. Bharadwaj,et al. Malnutrition: laboratory markers vs nutritional assessment , 2016, Gastroenterology report.
[31] T. Woodruff,et al. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis , 2015, Journal of the Neurological Sciences.
[32] F. Piehl,et al. Risk factors for amyotrophic lateral sclerosis , 2015, Clinical epidemiology.
[33] A. Chiò,et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. , 2014, JAMA neurology.
[34] A. Hattersley,et al. The clinical utility of C-peptide measurement in the care of patients with diabetes , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[35] L. Nguyễn,et al. Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms , 2013, Molecular Brain.
[36] J. Connor,et al. Plasma biomarkers associated with ALS and their relationship to iron homeostasis , 2010, Muscle & nerve.
[37] E. Novellino,et al. New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function. , 2009, Journal of medicinal chemistry.
[38] R. Batterham,et al. The role of peptide YY in appetite regulation and obesity , 2009, The Journal of physiology.
[39] I. Chiu,et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS , 2008, Proceedings of the National Academy of Sciences.
[40] A. Grierson,et al. Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.
[41] D. Larson,et al. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device , 2005, Perfusion.
[42] M. McGrath,et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) , 2005, Journal of Neuroimmunology.
[43] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Wikkelsø,et al. Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF , 1996, Journal of neurochemistry.
[45] J. Coyle,et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[46] R. Bowser,et al. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis , 2016, Neurotherapeutics.
[47] Y. Nakaya,et al. Serum albumin levels correlate with inflammation rather than nutrition supply in burns patients: a retrospective study. , 2014, The journal of medical investigation : JMI.